DarioHealth Corp.
NASDAQ:DRIO
0.9999 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 20.352 | 27.656 | 20.513 | 7.576 | 7.559 | 7.394 | 5.17 | 2.803 | 0.823 | 0.051 | 0 | 0 |
| Cost of Revenue
| 14.368 | 18.001 | 16.55 | 5.063 | 4.962 | 5.629 | 3.859 | 3.364 | 1.678 | 2.274 | 13.562 | 0 |
| Gross Profit
| 5.984 | 9.655 | 3.963 | 2.513 | 2.597 | 1.765 | 1.311 | -0.561 | -0.855 | -2.223 | -13.562 | 0 |
| Gross Profit Ratio
| 0.294 | 0.349 | 0.193 | 0.332 | 0.344 | 0.239 | 0.254 | -0.2 | -1.039 | -43.588 | 0 | 0 |
| Reseach & Development Expenses
| 20.248 | 19.649 | 17.219 | 4.433 | 3.692 | 3.676 | 3.297 | 2.154 | 2.565 | 3.943 | 4.912 | 1.501 |
| General & Administrative Expenses
| 18.14 | 16.493 | 23.532 | 12.756 | 5.483 | 5.468 | 4.726 | 3.378 | 2.948 | 3.64 | 6.296 | 2.177 |
| Selling & Marketing Expenses
| 23.785 | 30.323 | 39.706 | 15.227 | 11.127 | 10.309 | 7.707 | 4.739 | 1.33 | 1.063 | 2.354 | 0.296 |
| SG&A
| 41.797 | 46.816 | 63.238 | 27.983 | 16.61 | 15.777 | 12.433 | 8.117 | 4.278 | 4.703 | 8.65 | 2.473 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 62.045 | 66.465 | 80.457 | 32.416 | 20.302 | 19.453 | 15.73 | 10.271 | 6.843 | 8.646 | 13.562 | 3.974 |
| Operating Income
| -56.061 | -56.81 | -76.494 | -29.903 | -17.705 | -17.688 | -14.419 | -11.101 | -7.698 | -11.358 | -13.562 | -3.974 |
| Operating Income Ratio
| -2.755 | -2.054 | -3.729 | -3.947 | -2.342 | -2.392 | -2.789 | -3.96 | -9.354 | -222.706 | 0 | 0 |
| Total Other Income Expenses Net
| -3.302 | -5.379 | -0.235 | 0.458 | -0.031 | -0.097 | -1.153 | -0.035 | 0.578 | 1.672 | -0.294 | -1.606 |
| Income Before Tax
| -59.363 | -62.189 | -76.729 | -29.445 | -17.736 | -17.803 | -15.743 | -10.887 | -7.142 | -12.877 | -13.932 | -5.687 |
| Income Before Tax Ratio
| -2.917 | -2.249 | -3.741 | -3.887 | -2.346 | -2.408 | -3.045 | -3.884 | -8.678 | -252.49 | 0 | 0 |
| Income Tax Expense
| 0.064 | 0.004 | 0.032 | -0.458 | 0.031 | -0.115 | 1.324 | 0.055 | -0.556 | 2.008 | 0.369 | 1.712 |
| Net Income
| -54.86 | -62.193 | -76.761 | -28.987 | -17.767 | -17.803 | -15.743 | -10.887 | -7.142 | -12.877 | -13.932 | -5.687 |
| Net Income Ratio
| -2.696 | -2.249 | -3.742 | -3.826 | -2.35 | -2.408 | -3.045 | -3.884 | -8.678 | -252.49 | 0 | 0 |
| EPS
| -1.93 | -2.63 | -4.63 | -4.86 | -7.84 | -15.21 | -32.7 | -41.85 | -75.27 | -534.14 | -1,369.35 | -512.72 |
| EPS Diluted
| -1.93 | -2.63 | -4.63 | -4.86 | -7.84 | -15.21 | -32.7 | -41.85 | -75.27 | -534.14 | -1,369.35 | -512.72 |
| EBITDA
| -50.837 | -52.394 | -72.982 | -30.159 | -17.502 | -17.384 | -13.071 | -10.41 | -7.941 | -11.992 | -12.43 | -2.344 |
| EBITDA Ratio
| -2.498 | -1.894 | -3.558 | -3.981 | -2.315 | -2.351 | -2.528 | -3.714 | -9.649 | -235.137 | 0 | 0 |